ProMIS Neurosciences, Inc. (PMN)
13.07
-0.90
(-6.48%)
USD |
NASDAQ |
Sep 03, 16:00
13.07
0.00 (0.00%)
After-Hours: 20:00
ProMIS Neurosciences Total Assets (Quarterly) : 56.69M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.69M |
| March 31, 2026 | 67.41M |
| December 31, 2025 | 9.182M |
| September 30, 2025 | 21.46M |
| June 30, 2025 | 9.510M |
| March 31, 2025 | 13.65M |
| December 31, 2024 | 18.91M |
| September 30, 2024 | 24.51M |
| June 30, 2024 | 1.410M |
| March 31, 2024 | 3.548M |
| December 31, 2023 | 13.62M |
| September 30, 2023 | 17.88M |
| June 30, 2023 | 1.498M |
| March 31, 2023 | 4.428M |
| December 31, 2022 | 6.925M |
| September 30, 2022 | 5.382M |
| June 30, 2022 | 10.19M |
| March 31, 2022 | 14.44M |
| December 31, 2021 | 17.78M |
| September 30, 2021 | 23.07M |
| June 30, 2021 | 6.318M |
| March 31, 2021 | 7.471M |
| December 31, 2020 | 1.087M |
| September 30, 2020 | 0.5272M |
| June 30, 2020 | 1.131M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.106M |
| December 31, 2019 | 1.599M |
| September 30, 2019 | 0.5717M |
| June 30, 2019 | 1.158M |
| March 31, 2019 | 1.446M |
| December 31, 2018 | 2.172M |
| September 30, 2018 | 4.025M |
| June 30, 2018 | 5.505M |
| March 31, 2018 | 1.636M |
| December 31, 2017 | 1.733M |
| September 30, 2017 | 2.807M |
| June 30, 2017 | 0.7065M |
| March 31, 2017 | 1.694M |
| December 31, 2016 | 0.7217M |
| September 30, 2016 | 1.336M |
| June 30, 2016 | 0.7007M |
| March 31, 2016 | 0.9321M |
| December 31, 2015 | 0.8284M |
| September 30, 2015 | 1.217M |
| June 30, 2015 | 0.2072M |
| March 31, 2015 | 0.1655M |
| December 31, 2014 | 0.2543M |
| September 30, 2014 | 0.3029M |
| June 30, 2014 | 0.6749M |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 12.72M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.295M |
| Shareholders Equity (Quarterly) | 49.40M |
| Current Ratio | 7.855 |